This information reflects FDA's current analysis of data available to FDA concerning this drug. FDA intends to update this when additional information or analyses become available.
To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.
Healthcare Professional Information
Information for Healthcare Professionals: Ceftriaxone (marketed as Rocephin and generics)[ARCHIVED]
Information for Healthcare Professionals: Ceftriaxone (marketed as Rocephin) 9/2007[ARCHIVED]
FDA Alert (9/2007)
Ceftriaxone (marketed as Rocephin) Prescribing and Labeling Information
Regulatory history and labeling from Drugs@FDA